Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.310
-0.030 (-1.28%)
At close: Jul 9, 2026, 4:00 PM EDT
2.320
+0.010 (0.43%)
After-hours: Jul 9, 2026, 4:37 PM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $416 million as of July 9, 2026. Its market cap has increased by 14.82% in one year.
Market Cap
416.00M
Enterprise Value
231.11M
1-Year Change
14.82%
Ranking
Category
Stock Price
$2.31
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $416.00M, a decrease of -4.44%. That is a compound annual growth rate of -0.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 416.00M | -56.44% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Artiva Biotherapeutics | 445.07M |
| Sagimet Biosciences | 444.61M |
| Eupraxia Pharmaceuticals | 436.42M |
| Century Therapeutics | 435.56M |
| DiaMedica Therapeutics | 426.22M |
| vTv Therapeutics | 423.04M |
| Upstream Bio | 421.21M |
| Enanta Pharmaceuticals | 419.31M |